![logo](/logos/NP5.DE.webp)
Newron Pharmaceuticals SpA
FSX:NP5.DE
8.43 (EUR) • At close July 26, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Newron Pharmaceuticals SpA |
Symbool | NP5.DE |
Munteenheid | EUR |
Prijs | 8.33 |
Beurswaarde | 158,665,675 |
Dividendpercentage | 0% |
52-weken bereik | 4.26 - 12 |
Industrie | Pharmaceuticals, Biotechnology & Life Sciences |
Sector | Healthcare |
CEO | Prof. Stefan Weber |
Website | https://www.newron.com/ |
An error occurred while fetching data.
Over Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS)
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)